New birth control pill may be safer for your arteries
NCT ID NCT07536763
First seen Apr 18, 2026 · Last updated Apr 24, 2026 · Updated 1 time
Summary
This study tests if a newer combined oral contraceptive pill (estetrol-drospirenone) has fewer negative effects on blood vessel function and metabolic health than a standard pill. About 98 women aged 18-49 who want contraception or treatment for menstrual issues will take one of the two pills for 12 months. Researchers will measure artery flexibility, blood pressure, and blood markers to see if the newer pill is safer for long-term use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONTRACEPTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.